T46 Poisoning by, adverse effect of and underdosing of agents primarily affecting the cardiovascular system

Non-Billable/Non-Specific

Type 1 Excludes

poisoning by, adverse effect of and underdosing of metaraminol (T44.4)

Codes

T46.0Poisoning by, adverse effect of and underdosing of cardiac-stimulant glycosides and drugs of similar action
- T46.0XPoisoning by, adverse effect of and underdosing of cardiac-stimulant glycosides and drugs of similar action
  T46.0X1Poisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional)
  T46.0X1A..., initial encounter
  T46.0X1D..., subsequent encounter
  T46.0X1S..., sequela
  T46.0X2Poisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm
  T46.0X2A..., initial encounter
  T46.0X2D..., subsequent encounter
  T46.0X2S..., sequela
  T46.0X3Poisoning by cardiac-stimulant glycosides and drugs of similar action, assault
  T46.0X3A..., initial encounter
  T46.0X3D..., subsequent encounter
  T46.0X3S..., sequela
  T46.0X4Poisoning by cardiac-stimulant glycosides and drugs of similar action, undetermined
  T46.0X4A..., initial encounter
  T46.0X4D..., subsequent encounter
  T46.0X4S..., sequela
  T46.0X5Adverse effect of cardiac-stimulant glycosides and drugs of similar action
  T46.0X5A..., initial encounter
  T46.0X5D..., subsequent encounter
  T46.0X5S..., sequela
  T46.0X6Underdosing of cardiac-stimulant glycosides and drugs of similar action
  T46.0X6A..., initial encounter
  T46.0X6D..., subsequent encounter
  T46.0X6S..., sequela
T46.1Poisoning by, adverse effect of and underdosing of calcium-channel blockers
- T46.1XPoisoning by, adverse effect of and underdosing of calcium-channel blockers
  T46.1X1Poisoning by calcium-channel blockers, accidental (unintentional)
  T46.1X1A..., initial encounter
  T46.1X1D..., subsequent encounter
  T46.1X1S..., sequela
  T46.1X2Poisoning by calcium-channel blockers, intentional self-harm
  T46.1X2A..., initial encounter
  T46.1X2D..., subsequent encounter
  T46.1X2S..., sequela
  T46.1X3Poisoning by calcium-channel blockers, assault
  T46.1X3A..., initial encounter
  T46.1X3D..., subsequent encounter
  T46.1X3S..., sequela
  T46.1X4Poisoning by calcium-channel blockers, undetermined
  T46.1X4A..., initial encounter
  T46.1X4D..., subsequent encounter
  T46.1X4S..., sequela
  T46.1X5Adverse effect of calcium-channel blockers
  T46.1X5A..., initial encounter
  T46.1X5D..., subsequent encounter
  T46.1X5S..., sequela
  T46.1X6Underdosing of calcium-channel blockers
  T46.1X6A..., initial encounter
  T46.1X6D..., subsequent encounter
  T46.1X6S..., sequela
T46.2Poisoning by, adverse effect of and underdosing of other antidysrhythmic drugs, not elsewhere classified
- T46.2XPoisoning by, adverse effect of and underdosing of other antidysrhythmic drugs
  T46.2X1Poisoning by other antidysrhythmic drugs, accidental (unintentional)
  T46.2X1A..., initial encounter
  T46.2X1D..., subsequent encounter
  T46.2X1S..., sequela
  T46.2X2Poisoning by other antidysrhythmic drugs, intentional self-harm
  T46.2X2A..., initial encounter
  T46.2X2D..., subsequent encounter
  T46.2X2S..., sequela
  T46.2X3Poisoning by other antidysrhythmic drugs, assault
  T46.2X3A..., initial encounter
  T46.2X3D..., subsequent encounter
  T46.2X3S..., sequela
  T46.2X4Poisoning by other antidysrhythmic drugs, undetermined
  T46.2X4A..., initial encounter
  T46.2X4D..., subsequent encounter
  T46.2X4S..., sequela
  T46.2X5Adverse effect of other antidysrhythmic drugs
  T46.2X5A..., initial encounter
  T46.2X5D..., subsequent encounter
  T46.2X5S..., sequela
  T46.2X6Underdosing of other antidysrhythmic drugs
  T46.2X6A..., initial encounter
  T46.2X6D..., subsequent encounter
  T46.2X6S..., sequela
T46.3Poisoning by, adverse effect of and underdosing of coronary vasodilators
- T46.3XPoisoning by, adverse effect of and underdosing of coronary vasodilators
  T46.3X1Poisoning by coronary vasodilators, accidental (unintentional)
  T46.3X1A..., initial encounter
  T46.3X1D..., subsequent encounter
  T46.3X1S..., sequela
  T46.3X2Poisoning by coronary vasodilators, intentional self-harm
  T46.3X2A..., initial encounter
  T46.3X2D..., subsequent encounter
  T46.3X2S..., sequela
  T46.3X3Poisoning by coronary vasodilators, assault
  T46.3X3A..., initial encounter
  T46.3X3D..., subsequent encounter
  T46.3X3S..., sequela
  T46.3X4Poisoning by coronary vasodilators, undetermined
  T46.3X4A..., initial encounter
  T46.3X4D..., subsequent encounter
  T46.3X4S..., sequela
  T46.3X5Adverse effect of coronary vasodilators
  T46.3X5A..., initial encounter
  T46.3X5D..., subsequent encounter
  T46.3X5S..., sequela
  T46.3X6Underdosing of coronary vasodilators
  T46.3X6A..., initial encounter
  T46.3X6D..., subsequent encounter
  T46.3X6S..., sequela
T46.4Poisoning by, adverse effect of and underdosing of angiotensin-converting-enzyme inhibitors
- T46.4XPoisoning by, adverse effect of and underdosing of angiotensin-converting-enzyme inhibitors
  T46.4X1Poisoning by angiotensin-converting-enzyme inhibitors, accidental (unintentional)
  T46.4X1A..., initial encounter
  T46.4X1D..., subsequent encounter
  T46.4X1S..., sequela
  T46.4X2Poisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm
  T46.4X2A..., initial encounter
  T46.4X2D..., subsequent encounter
  T46.4X2S..., sequela
  T46.4X3Poisoning by angiotensin-converting-enzyme inhibitors, assault
  T46.4X3A..., initial encounter
  T46.4X3D..., subsequent encounter
  T46.4X3S..., sequela
  T46.4X4Poisoning by angiotensin-converting-enzyme inhibitors, undetermined
  T46.4X4A..., initial encounter
  T46.4X4D..., subsequent encounter
  T46.4X4S..., sequela
  T46.4X5Adverse effect of angiotensin-converting-enzyme inhibitors
  T46.4X5A..., initial encounter
  T46.4X5D..., subsequent encounter
  T46.4X5S..., sequela
  T46.4X6Underdosing of angiotensin-converting-enzyme inhibitors
  T46.4X6A..., initial encounter
  T46.4X6D..., subsequent encounter
  T46.4X6S..., sequela
T46.5Poisoning by, adverse effect of and underdosing of other antihypertensive drugs
- T46.5XPoisoning by, adverse effect of and underdosing of other antihypertensive drugs
  T46.5X1Poisoning by other antihypertensive drugs, accidental (unintentional)
  T46.5X1A..., initial encounter
  T46.5X1D..., subsequent encounter
  T46.5X1S..., sequela
  T46.5X2Poisoning by other antihypertensive drugs, intentional self-harm
  T46.5X2A..., initial encounter
  T46.5X2D..., subsequent encounter
  T46.5X2S..., sequela
  T46.5X3Poisoning by other antihypertensive drugs, assault
  T46.5X3A..., initial encounter
  T46.5X3D..., subsequent encounter
  T46.5X3S..., sequela
  T46.5X4Poisoning by other antihypertensive drugs, undetermined
  T46.5X4A..., initial encounter
  T46.5X4D..., subsequent encounter
  T46.5X4S..., sequela
  T46.5X5Adverse effect of other antihypertensive drugs
  T46.5X5A..., initial encounter
  T46.5X5D..., subsequent encounter
  T46.5X5S..., sequela
  T46.5X6Underdosing of other antihypertensive drugs
  T46.5X6A..., initial encounter
  T46.5X6D..., subsequent encounter
  T46.5X6S..., sequela
T46.6Poisoning by, adverse effect of and underdosing of antihyperlipidemic and antiarteriosclerotic drugs
- T46.6XPoisoning by, adverse effect of and underdosing of antihyperlipidemic and antiarteriosclerotic drugs
  T46.6X1Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, accidental (unintentional)
  T46.6X1A..., initial encounter
  T46.6X1D..., subsequent encounter
  T46.6X1S..., sequela
  T46.6X2Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, intentional self-harm
  T46.6X2A..., initial encounter
  T46.6X2D..., subsequent encounter
  T46.6X2S..., sequela
  T46.6X3Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, assault
  T46.6X3A..., initial encounter
  T46.6X3D..., subsequent encounter
  T46.6X3S..., sequela
  T46.6X4Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, undetermined
  T46.6X4A..., initial encounter
  T46.6X4D..., subsequent encounter
  T46.6X4S..., sequela
  T46.6X5Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs
  T46.6X5A..., initial encounter
  T46.6X5D..., subsequent encounter
  T46.6X5S..., sequela
  T46.6X6Underdosing of antihyperlipidemic and antiarteriosclerotic drugs
  T46.6X6A..., initial encounter
  T46.6X6D..., subsequent encounter
  T46.6X6S..., sequela
T46.7Poisoning by, adverse effect of and underdosing of peripheral vasodilators
- T46.7XPoisoning by, adverse effect of and underdosing of peripheral vasodilators
  T46.7X1Poisoning by peripheral vasodilators, accidental (unintentional)
  T46.7X1A..., initial encounter
  T46.7X1D..., subsequent encounter
  T46.7X1S..., sequela
  T46.7X2Poisoning by peripheral vasodilators, intentional self-harm
  T46.7X2A..., initial encounter
  T46.7X2D..., subsequent encounter
  T46.7X2S..., sequela
  T46.7X3Poisoning by peripheral vasodilators, assault
  T46.7X3A..., initial encounter
  T46.7X3D..., subsequent encounter
  T46.7X3S..., sequela
  T46.7X4Poisoning by peripheral vasodilators, undetermined
  T46.7X4A..., initial encounter
  T46.7X4D..., subsequent encounter
  T46.7X4S..., sequela
  T46.7X5Adverse effect of peripheral vasodilators
  T46.7X5A..., initial encounter
  T46.7X5D..., subsequent encounter
  T46.7X5S..., sequela
  T46.7X6Underdosing of peripheral vasodilators
  T46.7X6A..., initial encounter
  T46.7X6D..., subsequent encounter
  T46.7X6S..., sequela
T46.8Poisoning by, adverse effect of and underdosing of antivaricose drugs, including sclerosing agents
- T46.8XPoisoning by, adverse effect of and underdosing of antivaricose drugs, including sclerosing agents
  T46.8X1Poisoning by antivaricose drugs, including sclerosing agents, accidental (unintentional)
  T46.8X1A..., initial encounter
  T46.8X1D..., subsequent encounter
  T46.8X1S..., sequela
  T46.8X2Poisoning by antivaricose drugs, including sclerosing agents, intentional self-harm
  T46.8X2A..., initial encounter
  T46.8X2D..., subsequent encounter
  T46.8X2S..., sequela
  T46.8X3Poisoning by antivaricose drugs, including sclerosing agents, assault
  T46.8X3A..., initial encounter
  T46.8X3D..., subsequent encounter
  T46.8X3S..., sequela
  T46.8X4Poisoning by antivaricose drugs, including sclerosing agents, undetermined
  T46.8X4A..., initial encounter
  T46.8X4D..., subsequent encounter
  T46.8X4S..., sequela
  T46.8X5Adverse effect of antivaricose drugs, including sclerosing agents
  T46.8X5A..., initial encounter
  T46.8X5D..., subsequent encounter
  T46.8X5S..., sequela
  T46.8X6Underdosing of antivaricose drugs, including sclerosing agents
  T46.8X6A..., initial encounter
  T46.8X6D..., subsequent encounter
  T46.8X6S..., sequela
T46.9Poisoning by, adverse effect of and underdosing of other and unspecified agents primarily affecting the cardiovascular system
- T46.90Poisoning by, adverse effect of and underdosing of unspecified agents primarily affecting the cardiovascular system
  T46.901Poisoning by unspecified agents primarily affecting the cardiovascular system, accidental (unintentional)
  T46.901A..., initial encounter
  T46.901D..., subsequent encounter
  T46.901S..., sequela
  T46.902Poisoning by unspecified agents primarily affecting the cardiovascular system, intentional self-harm
  T46.902A..., initial encounter
  T46.902D..., subsequent encounter
  T46.902S..., sequela
  T46.903Poisoning by unspecified agents primarily affecting the cardiovascular system, assault
  T46.903A..., initial encounter
  T46.903D..., subsequent encounter
  T46.903S..., sequela
  T46.904Poisoning by unspecified agents primarily affecting the cardiovascular system, undetermined
  T46.904A..., initial encounter
  T46.904D..., subsequent encounter
  T46.904S..., sequela
  T46.905Adverse effect of unspecified agents primarily affecting the cardiovascular system
  T46.905A..., initial encounter
  T46.905D..., subsequent encounter
  T46.905S..., sequela
  T46.906Underdosing of unspecified agents primarily affecting the cardiovascular system
  T46.906A..., initial encounter
  T46.906D..., subsequent encounter
  T46.906S..., sequela
- T46.99Poisoning by, adverse effect of and underdosing of other agents primarily affecting the cardiovascular system
  T46.991Poisoning by other agents primarily affecting the cardiovascular system, accidental (unintentional)
  T46.991A..., initial encounter
  T46.991D..., subsequent encounter
  T46.991S..., sequela
  T46.992Poisoning by other agents primarily affecting the cardiovascular system, intentional self-harm
  T46.992A..., initial encounter
  T46.992D..., subsequent encounter
  T46.992S..., sequela
  T46.993Poisoning by other agents primarily affecting the cardiovascular system, assault
  T46.993A..., initial encounter
  T46.993D..., subsequent encounter
  T46.993S..., sequela
  T46.994Poisoning by other agents primarily affecting the cardiovascular system, undetermined
  T46.994A..., initial encounter
  T46.994D..., subsequent encounter
  T46.994S..., sequela
  T46.995Adverse effect of other agents primarily affecting the cardiovascular system
  T46.995A..., initial encounter
  T46.995D..., subsequent encounter
  T46.995S..., sequela
  T46.996Underdosing of other agents primarily affecting the cardiovascular system
  T46.996A..., initial encounter
  T46.996D..., subsequent encounter
  T46.996S..., sequela